HRSA Audits:
Are You Audit Ready?

Key Takeaways:

Presented By:

Justin Rolling
VP of National Sales

Anthony Velasquez
Chief Product Officer

340B WEBINAR:

© 2023 PharmaForce. All rights reserved.

Join us for this important webinar as we address the heightened scrutiny faced by CEs in the 340B Program.

With manufacturers, lawmakers, and private providers questioning the intent and compliance of the 340B program, Entities bear the burden of demonstrating their commitment to the program’s intent and mission. An average of 1 in 5 entities are grappling with adverse audit findings, often leading to repayments. In this session, we'll explore critical areas where program gaps may exist and provide actionable tactics to ensure a 100%-pass rate.

Explore the Current Landscape: Gain insights into the number of planned audits for the year, HRSA's progress, and the evolving audit environment in the 340B space.

Uncover Common Findings: Identify the most prevalent audit findings and pinpoint those that could result in repayments, ensuring proactive measures can be taken.

Swift Remediation Strategies: Discover practical steps entities can implement to promptly remediate findings, guaranteeing a seamless resolution process.

Best in KLAS^®. Three years and counting.

We’re proud to report that compared to the four largest TPAs in 340B, PharmaForce emerged as the overall best 340B Third Party Administrator with “A” ratings in every category, including overall performance, Culture, Loyalty, Operations, Product, Relationship, and Value—scoring a 91/100.

Demystify the HRSA Audit Process: Understand the audit process intricacies and learn from real-world entity experiences, unraveling what to expect during an audit

Who Should Attend:

Covered entities participating in the 340B program

Finance Directors

Program Managers

Pharmacy Directors

Anyone interested in learning more about the 340B program